Tiotropium/Salmeterol

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

HealthyPulmonary Disease, Chronic Obstructive

Phase 1

Relative Bioavailability of Tiotropium and Salmeterol After Inhalation of a Fixed Combined Dose Compared to Monocomponents in Healthy Male Volunteers

CompletedNCT02254174

Boehringer IngelheimHealthy

Start: 2006-03-31Updated: 2014-10-01

Phase 3

Tiotropium/Salmeterol Inhalation Powder in COPD

TerminatedNCT00668772

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2008-04-15End: 2008-11-21Updated: 2023-11-07